Genomic Focus
Unlock the Potential of Your Biomarkers
We partnered with Genomic Focus, a company founded by Matt Reidy, who personally experienced the impact of biomarkers in his battle with cholangiocarcinoma. After his journey, Matt Reidy sought to empower other cancer patients to unlock the potential of their biomarkers, thereby establishing Genomic Focus. Please view the video below by the Cholangiocarcinoma Foundation, where Matt Reidy shares his biomarker story.
Direct Link: https://www.youtube.com/watch?v=yh_IsL_WxS4
Genomic Focus
Biomarker results are obtained through molecular tissue profiling from a biopsy of a tumor or a liquid biopsy blood draw. Biomarkers play a crucial role in personalized medicine, enabling oncologists to identify the most effective therapies and clinical trial options for their patients. Further information on biomarkers is discussed on our Newly Diagnosed page.
Additionally, Genomic Focus offers an interactive clinical trial map for non-targeted clinical trials. Gallbladder cancer has been added to the dropdown menu in the non-targeted clinical trial map (refer to the screenshot below for reference).
A unique aspect of Genomic Focus is that you will receive an email when new clinical trials are available that match your specific biomarkers. This allows you and your medical team to stay up to date on all available options. Register and upload a copy of your biomarker report to start getting matched to personalized clinical trials.
Genomic Focus is FREE for patients and registration is simple. Just follow the steps below.
For the personalized clinical trials search gallbladder cancer is currently mapped to cholangiocarcinoma/biliary tract cancer. Your profile may indicate cancer type as cholangiocarcinoma.